# Single-cell RNA-Seq reveals changes in immune landscape in post-traumatic osteoarthritis

**Authors:** Aimy Sebastian, Nicholas R. Hum, Jillian L. McCool, Stephen P. Wilson, Deepa K. Murugesh, Kelly A. Martin, Naiomy Deliz Rios-Arce, Beheshta Amiri, Blaine A. Christiansen, Gabriela G. Loots

PMC · DOI: 10.3389/fimmu.2022.938075 · Frontiers in Immunology · 2022-07-29

## TL;DR

This study uses single-cell RNA sequencing to explore immune cell changes in mouse knee joints after ACL injury, revealing macrophage subtypes that may aid in joint repair.

## Contribution

The study identifies nine macrophage subtypes with unique gene expression patterns in post-traumatic osteoarthritis.

## Key findings

- Multiple immune cell types, including neutrophils, monocytes, and macrophages, accumulate in the joint after ACL injury.
- Macrophage subtypes like Lyve1hiFolr2hi and Trem2hiFcrls+ show phagocytic and growth factor-related gene enrichment.
- Cell type-specific gene expression changes are observed following ACL injury.

## Abstract

Osteoarthritis (OA) is the most common joint disease, affecting over 300 million people world-wide. Accumulating evidence attests to the important roles of the immune system in OA pathogenesis. Understanding the role of various immune cells in joint degeneration or joint repair after injury is vital for improving therapeutic strategies for treating OA. Post-traumatic osteoarthritis (PTOA) develops in ~50% of individuals who have experienced an articular trauma like an anterior cruciate ligament (ACL) rupture. Here, using the high resolution of single-cell RNA sequencing, we delineated the temporal dynamics of immune cell accumulation in the mouse knee joint after ACL rupture. Our study identified multiple immune cell types in the joint including neutrophils, monocytes, macrophages, B cells, T cells, NK cells and dendritic cells. Monocytes and macrophage populations showed the most dramatic changes after injury. Further characterization of monocytes and macrophages reveled 9 major subtypes with unique transcriptomics signatures, including a tissue resident Lyve1hiFolr2hi macrophage population and Trem2hiFcrls+ recruited macrophages, both showing enrichment for phagocytic genes and growth factors such as Igf1, Pdgfa and Pdgfc. We also identified several genes induced or repressed after ACL injury in a cell type-specific manner. This study provides new insight into PTOA-associated changes in the immune microenvironment and highlights macrophage subtypes that may play a role in joint repair after injury.

## Linked entities

- **Genes:** LYVE1 (lymphatic vessel endothelial hyaluronan receptor 1) [NCBI Gene 10894], FOLR2 (folate receptor beta) [NCBI Gene 2350], TREM2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 54209], Fcrl2 (Fc receptor like 2) [NCBI Gene 80891], IGF1 (insulin like growth factor 1) [NCBI Gene 3479], PDGFA (platelet derived growth factor subunit A) [NCBI Gene 5154], PDGFC (platelet derived growth factor C) [NCBI Gene 56034]
- **Diseases:** osteoarthritis (MONDO:0005178)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Hbegf (heparin-binding EGF-like growth factor) [NCBI Gene 15200] {aka Dtr, Dts, Hegfl}, Egr1 (early growth response 1) [NCBI Gene 13653] {aka A530045N19Rik, ETR103, Egr-1, Krox-1, Krox-24, Krox24}, S100a9 (S100 calcium binding protein A9 (calgranulin B)) [NCBI Gene 20202] {aka 60B8Ag, BEE22, Cagb, GAGB, L1Ag, MRP14}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 12772] {aka Cc-ckr-2, Ccr2a, Ccr2b, Ckr2, Ckr2a, Ckr2b}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Cenpa (centromere protein A) [NCBI Gene 12615] {aka Cenp-A}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, Adam8 (a disintegrin and metallopeptidase domain 8) [NCBI Gene 11501] {aka ADAM 8, CD156, CD156a, E430039A18Rik, MS2}, Vcan (versican) [NCBI Gene 13003] {aka 5430420N07Rik, 9430051N09, Cspg2, DPEAAE, PG-M, PG-M(V0)}, Gzma (granzyme A) [NCBI Gene 14938] {aka Ctla-3, Ctla3, Hf, Hf1, SE1, TSP-1}, Vim (vimentin) [NCBI Gene 22352], Spp1 (secreted phosphoprotein 1) [NCBI Gene 20750] {aka 2AR, Apl-1, BNSP, BSPI, Bsp, ETA-1}, Mxd1 (MAX dimerization protein 1) [NCBI Gene 17119] {aka Mad, Mad1}, Plac8 (placenta-specific 8) [NCBI Gene 231507] {aka C15, D5Wsu111e}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, Lcn2 (lipocalin 2) [NCBI Gene 16819] {aka 24p3, NRL, Sip24}, Csf1r (colony stimulating factor 1 receptor) [NCBI Gene 12978] {aka CD115, CSF-1R, Csfmr, Fim-2, Fim2, Fms}, C1QB (complement C1q B chain) [NCBI Gene 713] {aka C1QD2}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}, Mef2a (myocyte enhancer factor 2A) [NCBI Gene 17258] {aka A430079H05Rik}, Ctsb (cathepsin B) [NCBI Gene 13030] {aka APPM, CB}, Fabp5 (fatty acid binding protein 5, epidermal) [NCBI Gene 16592] {aka E-FABP, Fabpe, Klbp, PA-FABP, mal1}, ACVR1 (activin A receptor type 1) [NCBI Gene 90] {aka ACTRI, ACVR1A, ACVRLK2, ALK2, FOP, SKR1}, Ets2 (Ets proto-oncogene 2, transcription factor) [NCBI Gene 23872] {aka Ets-2}, Atf3 (activating transcription factor 3) [NCBI Gene 11910] {aka LRG-21}, Aqp1 (aquaporin 1) [NCBI Gene 11826] {aka CHIP28}, Ms4a7 (membrane-spanning 4-domains, subfamily A, member 7) [NCBI Gene 109225] {aka 9130422I10Rik, A430103C15Rik, CD20l4, CFFMA}, Cd74 (CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)) [NCBI Gene 16149] {aka CLIP, DHLAG, HLADG, Ia-GAMMA, Ii}, Cd163 (CD163 antigen) [NCBI Gene 93671] {aka CD163v2, CD163v3}, H2 (histocompatibility-2, MHC) [NCBI Gene 111364] {aka H-2, MHC-II}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, Mmp14 (matrix metallopeptidase 14 (membrane-inserted)) [NCBI Gene 17387] {aka MMP-X1, MT-MMP-1, MT1-MMP, sabe}, Igkc (immunoglobulin kappa constant) [NCBI Gene 16071] {aka Igk-C}, Cd209a (CD209a antigen) [NCBI Gene 170786] {aka CD209, CDSIGN, CIRE, DC-SIGN, DC-SIGN1, Dcsign}, S100a8 (S100 calcium binding protein A8 (calgranulin A)) [NCBI Gene 20201] {aka 60B8Ag, B8Ag, CFAg, CP-10, Caga, MRP8}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, Ifit2 (interferon-induced protein with tetratricopeptide repeats 2) [NCBI Gene 15958] {aka GARG-39, IFI-54K, Ifi54, P54}, LYVE1 (lymphatic vessel endothelial hyaluronan receptor 1) [NCBI Gene 10894] {aka CRSBP-1, HAR, LYVE-1, XLKD1}, Dab2 (disabled 2, mitogen-responsive phosphoprotein) [NCBI Gene 13132] {aka 5730435J12Rik, D15Wsu122e, D630005B22Rik, Doc-2, Doc2, p96}, Crip1 (cysteine-rich protein 1) [NCBI Gene 12925] {aka CRHP, CRP1, Crip}, Ccna2 (cyclin A2) [NCBI Gene 12428] {aka Ccn-1, Ccn1, Ccna, CycA2, Cyca}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, Ctsa (cathepsin A) [NCBI Gene 19025] {aka PPCA, Ppgb}, FOLR2 (folate receptor beta) [NCBI Gene 2350] {aka BETA-HFR, FBP, FBP/PL-1, FR-BETA, FR-P3, FRbeta}, Ctsl (cathepsin L) [NCBI Gene 13039] {aka 1190035F06Rik, CatL, Ctsl1, MEP, fs, nkt}, jt (joined toes) [NCBI Gene 16473] {aka syn}, Cd63 (CD63 antigen) [NCBI Gene 12512] {aka ME491, Tspan30}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, Ctsd (cathepsin D) [NCBI Gene 13033] {aka CD, CatD}, Ngp (neutrophilic granule protein) [NCBI Gene 18054] {aka bectenecin}, Chil3 (chitinase-like 3) [NCBI Gene 12655] {aka Chi3l3, ECF-L, Ym1}, Cd3e (CD3 antigen, epsilon polypeptide) [NCBI Gene 12501] {aka CD3, CD3epsilon, T3e}, Ifit3 (interferon-induced protein with tetratricopeptide repeats 3) [NCBI Gene 15959] {aka Ifi49, P49}, Gpnmb (glycoprotein (transmembrane) nmb) [NCBI Gene 93695] {aka DC-HIL, Dchil, ipd}, Cxcl2 (C-X-C motif chemokine ligand 2) [NCBI Gene 20310] {aka CINC-2a, GROb, Gro2, MIP-2, MIP-2a, Mgsa-b}, Ly6c1 (lymphocyte antigen 6 family member C1) [NCBI Gene 17067] {aka Ly-6C, Ly-6C1, Ly6c}, Klf4 (Kruppel-like transcription factor 4 (gut)) [NCBI Gene 16600] {aka EZF, Gklf, Zie}, Cxcl10 (C-X-C motif chemokine ligand 10) [NCBI Gene 15945] {aka C7, CRG-2, INP10, IP-10, IP10, Ifi10}
- **Diseases:** joint disease (MESH:D007592), liver injury (MESH:D017093), TC (MESH:D009408), cartilage damage (MESH:D002357), pain (MESH:D010146), inflammatory arthritis (MESH:D001168), PTOA (MESH:D004834), Joint injuries (MESH:D000092464), of the medial meniscus (MESH:D000070600), infection (MESH:D007239), inflammation (MESH:D007249), Knee joint injury (MESH:D007718), OA (MESH:D010003), post- (MESH:D000094025), articular trauma (MESH:D014947), tibial plateau fracture (MESH:D000092463), joint degeneration (MESH:D009410), meniscal (MESH:D010007), myocardial infarction (MESH:D009203), inflammatory response (MESH:D018746), ACL injury (MESH:D000070598), DM (MESH:D009223), intra-articular fractures (MESH:D057072), Alzheimer's disease (MESH:D000544), neuroinflammation (MESH:D000090862), joint pain (MESH:D018771), remodeling (MESH:D020257), osteophyte (MESH:D054850), bone remodeling (MESH:D001847), fibrosis (MESH:D005355), RA (MESH:D001172)
- **Chemicals:** ammonium-chloride (MESH:D000643), DAPI (MESH:C007293), paraffin (MESH:D010232), F12 (MESH:C007782), Fast Green (MESH:C035906), potassium (MESH:D011188), EDTA (MESH:D004492), buprenorphine (MESH:D002047), ACK (-), Safranin-O (MESH:C009195), PBS (MESH:D007854)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), C57Bl/6J — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0192), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), BL6 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0157)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC9373730/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC9373730/full.md

## References

95 references — full list in the complete paper: https://tomesphere.com/paper/PMC9373730/full.md

---
Source: https://tomesphere.com/paper/PMC9373730